Jean Guy (ODI Pharma and S-LAB): how many versions reach pharmacies and how do they differ

• Who supplies. 2 producers (ODI Pharma, S-LAB) in 2 positions, which may differ in declaration and origin of the raw material.
• Profile. It leads with caryophyllene, alongside bisabolol, nerolidol, terpinolene. We do not provide percentage shares because sources count them against different totals.
• Origin. Lineage is unknown. This is a result, not a gap to be filled: we do not add parents based on name similarity.
• What is missing. The profile describes one source, so there is nothing to compare it with.

What is this strain and where does it come from?

Jean Guy is a cannabis cultivar present in Polish pharmacy trade as a raw material dispensed by prescription, whose lineage is not confirmed by any available source. No one provides a pair of parent plants, and two pharmacy descriptions even differ regarding the type of plant. That is all that can be said about the origin of this strain without guessing.

Unknown lineage is not a gap that more precise searching will fill. It means that the breeder never disclosed the parents to the public or that the descriptions circulating in industry services contradict each other enough that accepting any of them would be fabrication. Among the 85 cultivars currently present in Polish pharmacies, 25 have such status, so Jean Guy is not an exception here, but part of a group that is not marginal at all.

The name tempts one to read its origin, and that is exactly why it should not be trusted. It sounds French, suggesting a Canadian trail, but the trade name does not record the cross and is often assigned long after the plant has entered cultivation. In the same set, the term kush is borne by both cultivars with established parents and those whose origin has not been confirmed, and the common word connects them only by sound. A lineage added by intuition creates false connections between strains and spoils the very graph that the reader was supposed to use for comparisons.

The discrepancy also includes the type of plant itself. One position describes this raw material as a hybrid, the other as a hybrid with a sativa predominance, although both refer to the same trade name. The division into indica and sativa actually comes from horticultural tradition, not measurement, so even a consistent entry would carry less information than one might expect.

Which producers supply this strain to Polish pharmacies?

Two manufacturers: ODI Pharma and S-LAB. Both positions enter the market as raw material dispensed by prescription under the same trade name, differing in declared potency, description of the type of plant, and scent notes in the documentation. The availability of individual series may be interrupted, so check the current state in the list of strains.

The declared potency is what divides these versions the most. The total range for both is 16.2-22.0%, and this comes from the fact that a deviation of up to ten percent in either direction is allowed from the label value. The number on the package describes the midpoint of the range in which a specific series falls, not the content of that one package. Both positions have different declared values, so the given range encompasses them together and does not describe either of them separately.

Availability changes from series to series and is not a feature of the plant itself. Imports may be interrupted, permits have their deadlines, and pharmacies order according to prescriptions, which means that a position present in the list a month ago can be unavailable today. The current state and compilation of all strains is maintained in the list of strains available in Polish pharmacies. What else both manufacturers supply is described in separate entries: ODI Pharma and S-LAB.

It is worth separating two things that often merge in the search engine. The raw material described in this text seems to be available only by prescription marked as Rpw, while hemp flower from retail sales is a different category of products, with a different composition and different dispensing method.

What does this strain smell and taste like?

• bisabolol bisabolol
• caryophyllene caryophyllene (leading in the pharmacy list)
• nerolidol nerolidol
• terpinolene terpinolene

Spicy and peppery, with a resinous background. Descriptions of both pharmacy versions converge on the peppery note, but diverge on the rest: one features camphor and a fruity accent, while the other leans towards a spiciness closer to kitchen spices. The impression also changes with the temperature of the heated flower.

The peppery note is attributed to caryophyllene, the same compound that gives spiciness to black pepper and cloves. In the profile of this strain, it has been recognized as leading, so the spicy notes in the ODI Pharma version and the peppery notes in the S-LAB version combine to form one image, even though they come from two separate descriptions. The camphor mentioned in one of them sounds like an exception, but fits within the same register: cool, sharp, without sweetness.

The rest of the set adds background. Terpinolene brings freshness similar to pine resin with a slight acidity, nerolidol adds a woody note with a floral tint, and bisabolol contributes a gentle chamomile-like note, which is usually only detectable once the sharper components have settled. The order in which these impressions appear depends on how quickly the temperature rises in the chamber.

The aroma remains a subjective description. There is no sensory panel for it, nor a unit; scent notes come from distributors and patients, and the same package can smell different after a month of storage. The taste during vaporization also changes with the temperature setting, as discussed below.

How long does it take for the strain to take effect and how long does the effect last?

This is determined by the route of administration, not the name of the strain. Vaporization provides initial sensations within a few minutes and encompasses the whole experience within a few hours, while oral administration delays the onset by half an hour to two hours and clearly extends the episode. No separate measurements have been published for Jean Guy itself.

The route of administration determines the course more than the strain itself, and the ranges below describe it, not this cultivar, as pharmacokinetic studies for a single cultivar have not been published.

With this strain, there is one more variable that is not related to physiology. The pharmacy versions from the two manufacturers have different declared values, so a portion measured from one package does not correspond to the same portion from the other. The course over time remains unchanged, but the intensity shifts, and those are two different things that are easily confused.

What is known and what is not known about the effects of this strain?

Almost nothing verified is known about the strain itself. There is no clinical study conducted on Jean Guy, but there are two works on caryophyllene, recognized in this profile as the leading terpene, as well as descriptions from manufacturers and patient reports, none of which have been compiled in a controlled comparison.

The profile composition is provided by one source, not two independent databases, and lists bisabolol, caryophyllene, nerolidol, and terpinolene. You will not find percentage shares next to these names intentionally: measured sums of shares in three compared sets were 46, 73, and 83 percent, meaning each source counts to a different total, and such numbers cannot be compared. One source also means that there is nothing to compare this composition with, and it is unknown whether the second database would describe it the same way.

The evidence for the terpene itself comes from mice.

Neither of the two studies tested caryophyllene on humans or in inhaled form from flower; both works concern oral or systemic administration in mice in pain and inflammation models, not sleep or mood.

On the other side stands what sounds like knowledge but is a commercial description. Terms like stimulating or balanced character come from product cards and have no measurement behind them, while patient reports describe individual experiences, not the property of the strain.

What side effects have been reported from this strain?

None attributed to this name. Reporting in safety monitoring is associated with a specific medicinal product and batch number, so there is no public compilation of symptoms for the Jean Guy cultivar. What can be reliably described pertains to hemp flower as a group of raw materials, not this one position.

Additionally, under this name, there are two products from different manufacturers, with different declared potencies. Even if someone were to collect reports by trade name, they would describe two separate series, not one plant, so the number assigned to the words Jean Guy would mislead the reader.

Reports of side effects are collected for a medicinal product with a batch number, not for the strain name, so the following pertains to hemp flower as a group of raw materials. The most frequently reported symptoms are dry mouth, red eyes, and increased heart rate. Dizziness upon rapid standing, daytime drowsiness, and transient worsening of short-term memory are less frequently described, as well as anxiety that increases with dosage. A separate issue is medications taken concurrently, especially sedatives and those affecting coagulation: their assessment requires knowledge of the entire list of preparations, not the description of the plant. We do not provide the frequency of these symptoms numerically, as public compilations for hemp flower in Poland do not separate them by individual products.

How to vaporize this strain?

Lower settings first release lighter scent components, while higher ones reach heavier ones, and caryophyllene from this profile is among the least volatile. The boiling temperatures from the tables refer to pure compounds under laboratory conditions, not to flower in the device chamber, so read them as a point of reference.

The differences between the components of this profile are significant. For terpinolene, public compilations of physicochemical properties report boiling around 183-185 degrees Celsius, for caryophyllene 256-259 degrees, for nerolidol 275-277 degrees, and for bisabolol, there is no reliable measurement in the same collection. If one were to read these numbers directly, it would imply that the leading component evaporates only above the threshold at which the flower begins to decompose, which is a false conclusion.

False because the same compilations report for caryophyllene 130 degrees at a pressure of 14 mmHg, meaning under reduced pressure. The same substance thus has two different values depending on measurement conditions, and neither reproduces what happens in the vaporizer chamber. Why such tables contradict themselves is described in a separate entry, as well as at what temperature terpenes evaporate from flower.

The practical conclusion is one: the setting on the display is not the temperature of the flower. Between the heating element and the material is airflow, packing density, and moisture of the raw material, which means that one setting in two devices gives two different courses. What is known about caryophyllene has been gathered in a separate text.

Which strains are related to it?

None whose relationship could be demonstrated. A list of siblings is built from the lineage graph, and with unknown parents, there is nothing to assemble it from. An empty list does not mean that the strain stands alone; it means that no common ancestors can be pointed out by any source today.

In the entire set, siblings fill 29 cultivars out of 85, and not because the rest lack data. An empty list can also be a correct result even with a known lineage when the parents are landraces or broad style families, as these are categories, not identified individual plants. Two strains sharing only such an ancestor are not yet siblings, just as two strains sharing one word in the name. With Jean Guy, the matter is simpler and less convenient: without established parents, there is no point of reference, so none of the remaining 84 positions in the set can be considered related.

Other ways of comparison remain. Strains with a similar profile composition are easier to find through individual components: caryophyllene, terpinolene, nerolidol, and bisabolol have their own entries collecting strains in which they are described. The full list of cultivars available in Polish pharmacies is in the strain compilation, updated along with changes in trade.

Frequently asked questions

Below are collected questions that repeat regarding this strain, along with how much can be answered with available sources. Where there is no answer, it is stated directly, instead of filling the space with a general description of the raw hemp material.

Is Jean Guy a sativa or a hybrid?

Sources provide different answers. One pharmacy position describes this raw material as a hybrid, the other as a hybrid with a sativa predominance, although both refer to the same trade name. The division itself comes from horticultural tradition, not laboratory measurement, so even a consistent entry would not say much about the composition of the raw material.

How many producers supply Jean Guy to Polish pharmacies?

Two: ODI Pharma and S-LAB. Each introduces its own position under the same trade name, and the positions differ in declared potency and description of the type of plant. The availability of series changes over time, so the current state must be checked in the list, not in this text.

What THC content is reported for the Jean Guy strain?

A range of 16.2-22.0%, encompassing both pharmacy positions together. A single number from the label describes the declared value, from which a deviation of up to ten percent in either direction is allowed, which is why we provide a range instead of one value.

Is the lineage of the Jean Guy strain known?

No. No available source provides a pair of parent plants for this cultivar, so the lineage remains unknown. The French sound of the name is not an indication of origin, as the trade name does not record the cross.

Which terpene has been recognized as leading in this profile?

Caryophyllene. This is stated by the only source describing the composition of this strain, listing bisabolol, nerolidol, and terpinolene alongside it. We do not provide percentage shares because sources count them to different totals and cannot be compared.

Can Jean Guy be purchased without a prescription?

No. Hemp flower of this category is a pharmaceutical raw material dispensed only by prescription marked as Rpw, issued by a doctor. Retail cannabis products belong to a different category and have a different composition.

This text is for informational purposes only and does not replace medical consultation. The hemp flower described above is a pharmaceutical raw material dispensed only by a doctor’s prescription in the Rpw category. Prepared by: ubucha.